The novel coronavirus, which has killed 2.65 million people globally
since it emerged in China in late 2019, mutates around once every
two weeks, slower than influenza or HIV, but enough to require
tweaks to vaccines.
Sharon Peacock, who heads COVID-19 Genomics UK (COG-UK) which has
sequenced half of all the novel coronavirus genomes so far mapped
globally, said international cooperation was needed in the "cat and
mouse" battle with the virus
"We have to appreciate that we were always going to have to have
booster doses; immunity to coronavirus doesn't last forever,"
Peacock told Reuters at the non-profit Wellcome Sanger Institute's
55-acre campus outside Cambridge.
"We already are tweaking the vaccines to deal with what the virus is
doing in terms of evolution - so there are variants arising that
have a combination of increased transmissibility and an ability to
partially evade our immune response," she said.
Peacock said she was confident regular booster shots - such as for
influenza - would be needed to deal with future variants but that
the speed of vaccine innovation meant those shots could be developed
at pace and rolled out to the population.
COG-UK was set up by Peacock, a professor at Cambridge, exactly a
year ago with the help of the British's government's chief
scientific adviser, Patrick Vallance, as the virus spread across the
globe to Britain.
The consortium of public health and academic institutions is now the
world's deepest pool of knowledge about the virus's genetics: At
sites across Britain, it has sequenced 346,713 genomes of the virus
out of a global effort of around 709,000 genomes.
On the intellectual frontline at the Wellcome Sanger Institute,
hundreds of scientists - many with PhDs, many working on a voluntary
basis and some listening to heavy metal or electronic beats - work
seven days a week to map and then search the virus's growing family
tree for patterns of concern.
Wellcome Sanger Institute has sequenced over half of the UK total
sequenced genomes of the virus after processing 19 million samples
from PCR tests in a year. COG-UK is sequencing around 30,000 genomes
per week - more than the UK used to do in a year.
[to top of second column] |
MUTATION LEADERBOARD
Three main coronavirus variants - which were
first identified in Britain (known as B.1.1.7),
Brazil (known as P1)and South Africa (known as
B.1.351) - are under particular scrutiny.
Peacock said she was most worried about B.1.351.
"It is more transmissible, but it also has a
change in a gene mutation, which we refer to as
E484K, which is associated with reduced immunity
- so our immunity is reduced against that
virus," Peacock said.
With 120 million cases of COVID-19 around the
world, it is getting hard to keep track of all
the alphabet soup of variants, so Peacock's
teams are thinking in terms of "constellations
of mutations."
"So a constellation of mutations would be like a
leaderboard if you like - which mutations in the
genome that we're particularly concerned about,
the E484K is must be one of the top of the
leaderboard," she said.
"So we're developing our thinking around that
leaderboard to think, regardless of the
background and lineage, about what mutations or
constellation of mutations are going to be
important biologically and different
combinations that may have slightly different
biological effects."
Peacock, though, warned of humility in the face
of a virus that has brought so much death and
economic destruction.
"One of the things that the virus has taught me
is that I can be wrong quite regularly - I have
to be quite humble in the face of a virus that
we know very little about still," she said.
"There may be a variant out there that we
haven't even discovered yet."
There will, though, be future pandemics.
"I think its inevitable that we will have
another virus emerge that is of concern. What I
hope is that having learned what we have in this
global pandemic, that we will be better prepared
to detect it and contain it."
(Reporting by Guy Faulconbridge; Editing by Kate
Holton and Philippa Fletcher)
[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content |